Glialogix Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Glialogix General Information

Description

Operator of a biotechnology firm intended to develop therapeutics for neurodegenerative disease. The company's product is an improved proprietary formulation of an existing approved drug and is being developed for the treatment of progressive multiple sclerosis, enabling doctors to help patients slow the progression of chronic neurodegenerative diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 38 Bayo Vista Avenue
  • Larkspur, CA 94939
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 38 Bayo Vista Avenue
  • Larkspur, CA 94939
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glialogix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 18-Jul-2022 Completed Out of Business
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator 01-Jan-2013 Completed Startup
1. Grant 11-Feb-2012 $268K Completed Startup
To view Glialogix’s complete valuation and funding history, request access »

Glialogix Patents

Glialogix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200009118-A1 Compositions and methods for the treatmentof neurodegenerative and other diseases Inactive 21-Oct-2016
US-20180110760-A1 Compositions and methods for the treatmentof neurodegenerative and other diseases Inactive 21-Oct-2016
JP-2016507526-A Compositions and methods for the treatment of neurodegeneration and other diseases Active 01-Feb-2013
US-9918997-B2 Compositions and methods for the treatment of neurodegenerative and other diseases Inactive 01-Feb-2013
JP-2018123159-A Compositions and methods for treating neurodegenerative and other diseases Pending 01-Feb-2013 A61K31/635
To view Glialogix’s complete patent history, request access »

Glialogix FAQs

  • When was Glialogix founded?

    Glialogix was founded in 2008.

  • Where is Glialogix headquartered?

    Glialogix is headquartered in Larkspur, CA.

  • What industry is Glialogix in?

    Glialogix’s primary industry is Drug Discovery.

  • Is Glialogix a private or public company?

    Glialogix is a Private company.

  • What is Glialogix’s current revenue?

    The current revenue for Glialogix is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »